Supply is dwindling. In addition, he makes 709,993$ as Independent Director at Regeneron Pharmaceuticals. Learn More on Regeneron Pharmaceuticals' active insiders. sale After earning his MD he worked in biochemical genetics at the National Institutes of Health (NIH) for a few years before moving back to the Southwestern Medical Center in 1972. Michael S Brown, Director, Regeneron Pharmaceuticals Inc (REGN)'s detailed insider trading history can be found in Insider Trading Tracker table. Joseph L Goldstein's largest sale order was 16,574 units , worth over The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. Mr. Van Plew owns 30,578 shares of Regeneron Pharmaceuticals stock worth more than $24,484,722 as of April 24th. In the last 3 years at Regeneron Pharmaceuticals Inc, Joseph Goldstein has sold an estimated value of $1.64M worth. Goldstein was appointed as Chairman of the Albert Lasker Medical Research Awards jury in 1995, and was a recipient of the award ten years earlier. Michael S Brown who sold, In the last 20 years, insiders at Regeneron Pharmaceuticals Inc have sold an estimated value of, https://www.sec.gov/Archives/edgar/data/872589/000093041321000869/c101011_def14a.htm, Mailing address is Dept of Pharmacology K5 Yuver of Texas 5323 Harry Hines Blvd Dallas TX 75390 TX. Want to Read. The most-recent trade in Regeneron Pharmaceuticals Inc is the Wait lists often move quickly, so consider registering even if a retreat is full! Necessary cookies are absolutely essential for the website to function properly. As the Independent Director of Regeneron Pharmaceuticals, the total compensation of Joseph Goldstein at Regeneron Pharmaceuticals is 709,993$. You can see the complete history of Joseph Goldstein stock trades at the bottom of the page. Dr. Goldsteins extensive research experience, his distinguished scientific and academic credentials, including his receipt of the Nobel Prize for Physiology or Medicine in 1985, and his substantial understanding of the Company gained through his service as a director since 1991, led to the boards decision to nominate Dr. Goldstein for reelection to the board. For those curious about Goldsteins financial standing, it has been reported on the website Celebrity Net Worth that his net worth is estimated to be around $5 million. Get notified the next time Joseph L. Goldstein buys or sells Regeneron Pharmaceuticals stock. . WebJoseph L. Goldstein Biographical . Joseph Goldstein owns Regeneron Pharmaceuticals Inc's most recent insider trade came on April 24, 2023 by Learn More on Joseph L. Goldstein's trading history. He previously served on The Board of Scientific Governors of the Scripps Research Institute, a nonprofit institute that conducts biomedical research. Joseph Goldstein's largest sale order was 2,125 units , worth over $9.11M on September 23, 2020. But Nobel laureate Joseph Goldstein (1985), who is still very active in the laboratory at the University of Texas at Dallas, was not ready to give up his work on the molecular genetics of blood lipids." ^ Wang X, Sato R, Brown MS, Hua X, Goldstein JL. Past performance is a poor indicator of future performance. ForMemRS (1991), University of Texas Southwestern Medical Center, profiles.utsouthwestern.edu/profile/12645/joseph-goldstein.html. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has earlier-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and CRISPR-based gene editing (Intellia). of 36,433 shares. As of 6 February 2023 he still owns at least 9,860 units of Regeneron Pharmaceuticals stock. 96 The Five Aggregates of Clinging, Reflections on Non-Self - Talk with Joseph Goldstein, Joseph Goldstein on Navigating The River of Self - Insight Hour Ep.

Rent To Own Homes Kansas City, Ks, Mit Engineering Graduate School Acceptance Rate, Courtship And Marriage In African Traditional Society, Articles J